Echo IQ Shares Surge 25% After FDA Clears AI Solution for Aortic Stenosis

By Yahoo! Finance | Oct 10, 2024 at 10:03 AM EST

Australian biotech firm Echo IQ saw a 25% surge in stock price after receiving FDA clearance for its AI-driven cardiovascular diagnostic tool. The company is set to capitalize on commercial opportunities in the U.S. healthcare market with innovative solutions like EchoSolv AS.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.